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Summary
We present six adult patients from three separate families, with disease. Skeletal muscle biopsies (and a specimen of ocular
muscle) revealed ragged-red fibres. Autopsy examination in
systemic involvement o f  thereve
a remarkably uniform heredo-ataxic syndrome, developing in 
three stages and ending in early death. The initial stage is 
determined by severe sensory neuropathy. The second stage
is characterized further by progressive external ophthalmo- dorsal columns and spinocerebellar tracts, 
plegia (PEO),
nervous system, with, in particular, degeneration of spinal
caused bv oc • m v ( were H’ an recessi ve disorder.
progressive ataxia. During a short last stage there is epilepsia, Additional findings, particularly elevation of CSF lactate, 
and particularly myoclonic status epilepticus, o f which four suggested mitochondrial cytopathy as an essential feature of 
patients died unexpectedly. Sural nerve biopsies showed the multisystem degeneration in these patients.
severe loss o f  myelinated fibres in a rather early stage o f
Keywords: sensory neuropathy; progressive external 3gia; ataxia; myoclonus epilepsia; mitochondrial
Abbreviations: COX = cytochrome c oxidase; CPEO s inigiin chronic progressive external ophthalmoplegia with multisystemic
involvement; KSS = Kearns-Sayre syndrome; MEM = mitochondrial encephalomyopathy; MERRF «  myoclonus epilepsy 
with ragged-red libres; mtDNA = mitochondrial DNA; PEO = progressive external ophthalmoplegia
MMP mm*
Introduction
Without knowing the underlying molecular genetic mechan­
isms, the classification of hereditary multisystem disorders,
myopathy, fatigue, polyneuropathy, ataxia and seizures 
(Lombes et a/., 1989; DiMauro and Moraes, 1993), Pro-
presenting as heredo-ataxic syndromes, has traditionally been gressive sensory axonal neuropathy is a common finding in 
the subject of controversy. The establishment of a growing 
number of underlying inborn errors of metabolism, of which erations to a lesser degree,
the primary mitochondrial dysfunction currently attracts much reported in mitochondrial encephalomyopathie (MEM) syn- 
attention, resulted in the lumping together of disorders, that dromes (Yiannikas et al., 1986; Mizusawa et a I., 1991).
were previously distinguished on clinical grounds (Rosenberg
and Grossman, 1989; Marsden et al,, 1990; Harding 
On the other hand, genetically or
We now present six adult patients from three families with 
a progressive neurological disorder, characterized by insidious
onset at adolescence of severe sensory neuropt
mitochondrial diseases seem to have an expanding number patients subsequently developed PEO, gait ataxia, with slight
cerebellar symptoms, and myoclonic status epilepticus in aof non-specific, clinical features, inc 
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Table I Clinical and biochemical characteristics'
Patient no. Normal values
A.S3 A.S4 A.S6 B.S6 B.S9 C.F1
Age of onset (years) 20 <20 18 20 17 <18
Age of death (years) 44 32 36 32
Neuropathy «I»# +  +  + +  +  +
CPEO l%|ik - i _  - j . +  + +  +  +
Dysarthria +  + + + + + +  + +
Epilepsy — Myocl status Myocl status Myocl status Absences Myocl status
Blood lactate (jimol I-1) 255 6 3130 1300* 9• 2575 1340* 700-1800
Urine lactate 31 1012 73 9« 92 30 <60
((.tmol mmol creatine-1)
CSF lactate (jLtmol I-1) 2982 < 4 0 > 2850 < 25> 2500 <21 > 71 2110 <45 > to 4 
fr- A to -P^ V 140-1900
CSF protein (mg I-1) 361 650 685 633 420 550 180-580
Blood and CSF lactate vi in resting condition.+ =  mild; + +  = moderate; + +  +  = severe; 7 not available; <  >  =  age of
investigation. *The normal values for the laboratory conditions concerned were given as 600-1200 and 1200-1600 ¡.tniol 1 in blood and 
CSF, respectively.
short last stage. This multisystem degeneration neither fits in wheelchair by the age of 29 years, with complete external
any of the heredo-ataxic syndromes in the most recent ophthalmoplegia, visual acuteness of 0.5, areflexia and slight
classification (Harding, 1993), nor could it be identified as one muscular weakness. At the age of 29 years she gradually
of the previously established MEM syndromes. Additional developed myoclonic jerks in the legs, initially particularly
findings suggest mitochondrial involvement as an essential at night. At the age of 31 years grand mal epilepsy with
feature. myoclonus of both hands developed, followed by repeated
epileptic insults and fatal myoclonic epileptic status after 8
Case summaries (Table 1)
months. No autopsy was performed.
Patient A.S3 developed numbness in the legs, fatigue and
Family A
Three patients from this family (Fig. 1) were affected. The 
parents of these patients exhibited no symptoms, neither did 
they suffer from any complaints. Patient A.S4 had complaints
of progressive gait from the age of 20
onward, but had clumsy performance before that. On clinical 
examination at the age of 31 years, there were severe sensory 
neuropathy (with loss of vibration and position sense but 
intact nociception), areflexia, ataxia with slight cerebellar 
signs (particularly dysarthria and slight dysmetria), and 
ophthalmoparesis (particularly upward gaze) with symmetric 
ptosis. At the age of 32 years she had two grand mal insults,
chronic episodic diarrhoea, after delivery of a healthy boy 
when she was aged 25 years. Endoscopy and radiology of 
the gastrointestinal tract revealed no abnormalities. Bedside 
testing of autonomic functions, including orthostatic changes 
of blood pressure, ECG changes of heart rate at rising, 
Valsalva manoeuvre and hyperventilation (McLeod and Tuck, 
1987) showed normal responses. From the age of 30 years 
onward there were severe sensory ataxia, PEO (without visual 
loss), dysarthria with slight discoordination, areflexia, mild 
muscular weakness, distal loss of sensibility for all qualities, 
and loss of position, vibration and discrimination sense from 
the trunk extending down the legs. The feet were high-arched
followed by gradually progressive myoclonus, particularly and there was thoracolumbar scoliosis. At the age of 40 years
of the right side of the body. At the age of 33 years there she could not walk without aid, there was complete external
was repeated myoclonic epileptic .status (see the EEG trace, ophthalmoplegia, but no clinical signs of epilepsia. The EEG
Fig. 2A), of which she died at the age of 34 years; autopsy showed recurrent paroxysmal bitemporal sharp waves, with
was performed. a tendency to spread, yet without clinical signs of epilepsy.
Patient A.S6 also had sub-optimal motor performance at 
school age, and complained of muscle stiffness and pains in 
the legs, with fatigue and unsteady gait, from the age of 18 Family B
years onward. She was admitted at a psychiatric hospital Patient B.S9 had absence-like attacks at the time of menarche
because of anxiety and severe psycholability with ‘delusions’ for which she received anticonvulsants for some years. From
for several years. At the age of 21 years there were ataxia, the age of 17 years onward she complained 
dysarthria, kyphoscoliosis, pes cavus and partial external hypersensitive and abnormal temperature sensations in both
ophthalmoplegia with asymmetric ptosis. Autonomic neuro- legs. Examination at the age of 20 years revealed pes cavus, 
pathy was considered because of orthostatic hypotension, sensory ataxia with normal muscle strength and
hyperhydrosis, keratitis sicca and a tendency to urine- ophthalmoplegia (with symmetric ptosis). There was loss of
retention, with recurrent cystitis. She was confined to a discrimination and vibration sense for the lower part of the
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Fig. 1 Pedigrees of families A, B and C. Arrow ¿x patient.
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body and loss of nociception of the feet. Furthermore, there examination was given. His mother, sister and nephew were 
were keratitis sicca, suboptimal vision (0.8/0.7), but no retinal examined, but they did not show any related signs. His father
degeneration, chronic recurrent cystitis and uncomprehended 
precordial sensations. At the age of 50 years she was 
wheelchair bound, and there were near-total external 
ophthalmoplegia, areflexia, slight dysarthria, some distal 
muscle waste and relatively good strength of proximal 
muscles. The EEG (Fig. 2B) demonstrated evidence of 
generalized paroxysmal 3 s_1 spike-and-wave discharges on 
hyperventilation, without clinical vseizures ever since puberty. 
The patient was treated with coenzyme Q 10 and experienced 
remarkable subjective improvement of well-being.
The case history of her sister, patient B.S6, has 
reported before as an atypical case of chronic PEO with
was not available for examination, but was reported by his 
ex-wife to be in good health.
Results of additional investigations 
Laboratory investigation (see also Table 1)
Metabolic, endocrinological, immunological or chronic infec­
tious diseases were excluded by appropriate investigations.
V i * par arly serum creatine kinase,
ammonia, phytanic acid, purines and pyrimidines, lysosomal 
enzymes, transfemne, copper, caeruloplasmin, vitamins B
, paraprotein ; C s were
involvement (CPEO-pIus) with Friedreich’s normal. Tests for hypo-betalipoproteinaemia and
ataxia (Bastiaensen et a l, 1977). She suffered from increasing fatty acid metabolism, including carnitine normal
psycholability and pain in the legs, with ataxia and PEO, results. Serum organic acids and amino acids were normal,
from the age of 25 years onward. These signs became evident 
after her first, and more markedly after the second pregnancy,
the variably lactate, and glycine or
alanine in Patients A.S3, A.S6 and B.S9. Examination of 
at the age of 28 years. She gradually developed myoclonic CSF consistently showed increase of lactate, at an early age,
epilepsy at the age of 36 years, and died in myoclonic in all patients, with normal counts, no elevation of
epileptic status ~1 year later. at post-mortem immunoglobulins and mild elevation of protein in some
examination were similar to those reported in case A.S4. Her cases. Lactate concentrations in blood and 24 h urine samples, 
sister, Patient B.S2, died at the age of -2 0  years, probably obtained under normal conditions, were less consistently 
of myoclonic epileptic status, some time after delivery of a 
healthy child. Retrospectively she
elevated.
had shown an
abnormal gait and may have suffered from the same disorder. 
The mother (B.M1) suffered from benign idiopathic epilepsy, 
without signs of neuropathy or ophthalmoplegia at an old 
age; the father was in good health.
Electrophysiological studies (Table 2)
For stimulation and i ition of nerve conduction
velocities, maximal compound motor axon potential and 
sensory nerve action potential, surface electrodes were used 
according to standard methods. Examination of the peripheral 
nerves showed marked reduction of sensory nerve actionFamily C
Patient C.F1 was seen at the age of 7 years by a neurologist, potentials (and to a lesser degree compound motor axon 
because of clumsy performance, but no abnormalities were potentials), with relatively slowing
shown. Sensory neuropathy, with 
particularly dysarthria, were reported from the age of
velocities and distal latencies. Involvement of proximal nerves 
and nerve roots was suggested by slowing and amplitude
years onward. Later on he also complained of dysphagia, reduction of Hoffmann reflexes. Concentric needle EMG of
precordial sensations and diarrhoea.
cardiological examination revealed no signs of cardiomyo­
pathy. He was referred to our department at the age of 24 
years, because of PEO with symmetric ptosis, polyneuropathy 
with areflexia and some wasting of peroneal muscles and
at least two muscles (proximal and distal) showed mild signs 
of denervation or neurogenic dysfunction in all cases, but no
the ocularmyopathic changes. The EMCiI
muscles in case B.S6, however, suggested ocular myopathy.
intrinsic muscles of hands and feet. Myoclonic
at the age of 32 years, Sural nerve biopsies (Table 3; Figs 3 and
previous signs of epilepsy. He was admitted to an intensive A whole sural nerve biopsy was performed at the mid-call' 
care unit, where he died after 1 month of treatment for level, in all patients except A.S3, and prepared for light and
myoclonic epileptic status. No permission for post-mortem examinad on, i n ciudi nu; ■e
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Patient no. Normal values
A.S3 A.S4 A.S 6 B.S6 C.F1
Age (years) 40 25 30 50 25
N. suralis
SNAP 0-iV) 0.0 0.0 0.0 0.0 0.0
N. peroneus
CV (m s *) 39 41 37 30 — > 5 2
CMAP (mV) 2.4 NA NA 0.2 0.0 >2.0
N. medianus
CV!l: (m s_1) 56 49 45 55 51 >53
DL (ms) 2.6 o 7émté t f 2.9 3.5 3.7 <2.6
SNAP (|iV) 0.0 2.0 2.0 0.0 0.0 > 1 0
CMAP (mV) 13 NA 20 14.8 5.6 >3.0
H-reflex m. soleus
H CMAP (mV) 6.5 15 29 6.0 0.3
H-M interval (ms) 38.2 31.4 NA 32.6 32.3 <27
Values of left and right side were comparable. SNAP =  sensory nerve action potential; CV = conduction velocity; CMAP =  compound
motor axon potential; NA = not available from reports or no response; DL = distal latency. *If no SNAP arousable, then CV calculated
from motor response.
Table 3 Morphological findings in sural nerve biopsies
Patient no. Normal values
A.S A.S6 B.S6 B.S C.F1
Age (years) 25 34 37 36 24 (21-40)
MF density (1 m n r ) 1540 <500 <500 2005 1200 10 210 ± 2200 (n = 9)
MF size histogram
% MF < 4  nm 71 100 100 85 97 40% ±11% (// = 9)
% MF >6.5  )iim 1 0 0 1 0 33%±4% (n — 9)
TTFA (mnr) 0.36 NA NA 0.28 0.19 0,85 ±  0.31 (n = 4)
MF =  myelinated fibre; NA = not available; TTFA = total transverse fascicular area.
Fig. 3 Sural nerve specimen.
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sural nerve of patient A.S4 showing severe
myelinated fibres of which only some small fibres are left, and massive increase of endoneural collagen. Bar 
magnification showing nn :ells, mostly of the unmyelinated type (arrows). Bar
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= 2 Lim.
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Fig. 4 Diameter histograms of myelinated libres (outlined areas) of patient A.S4 (À), patient B.S9 (B) and patient C.FI (C), in
comparison with age-matched control (hatcheicl areas).
Table 4 Morphological and biochemical findings in muscle biopsies related to mitochondria / involvement
Patient no.
A.S4 A.S6 B.S6 B.S9 C.FI
Age (years) 25 29
i
36 36 25
Muscle Soleus Quadriceps Ocular Soleus Quadriceps
RRF (LM) i n | m 0* W  |  mm
Fibre type grouping 0 +  + +
Abnormal ultrastructure of mitochondria1 + +  + _|_ -|-
COX (nmol min-1 mg protein-1)* 145 210s 103 307
0 = not present;+  =  present; + + =  markedly present; RRF =  ragged red libres; LM =
increased number of subsarcolemmal mitochondria; 'morphological changes and paracrystalline inclusions (Fig. 5): * normal values:
: investigation. ^Significantly
73-284 nmol min 1 mg protein 1 in supernatant; ^deficient COX activity in single muscle fibres (Fig. 5E and F).
and morphometry, using standard 
(Gabreels-Festen e t  a l , 1991). Sural nerves of all examined 
patients showed severe reduction of myelinated f i b r e  density 
(Fig. 3A). Clusters of regenerated fibres were hardly present; 
active axonal degeneration was not observed. Teased fibre 
studies showed clustering of paranodal and segmental 
demyelination and
according to standard methods (Dubowitz and Brooke, 1973 ). 
In cases A.S4, A.S6, B.S6 and C.FI, at ages between 25 and 
36 years, 0.5-2% of ■es were nmceci-re •es. In
case B.S9 (the patient who was the least severely affected
ation
clinically) local elevation of succinate dehydrogenase activity 
suggested subsarcolemmal accumulation of mitochondria. In 
the light microscopic preparation of case A.S6, most of the 
suggestive of neuronal or axonal atrophy. Fibre diameter ragged-red fibres were type I fibres, with absent cytochrome 
distribution was unimodal with a peak at 2-4 |xm diameter 
and near total loss of large diameter fibres (Fig. 4). Electron 
microscopic studies revealed severe loss of myelinated and, 
apparently, also unmyelinated axons, leaving behind denerv- 
ated, thin Schwann cell bands, among areas of collagen fibres
M  O > of the normal looking
4 ttype 1 fibres also showed decreased or absent COX activity 
(Fig. 5F). Electron microscopic examination additionally 
established abnormal mitochondria, with increased size, and
; inclu-disarrangement of cristae, and typical 
(Fig. 3B). In case A.S4 sural nerve biopsy at the age of 26 s i o n s ,  particularly in the area of accumiil 
years was compared with sural nerve obtained at post-mortem jn Patients A.S4, A.S6, B.S6 and C.FI. 
examination, at the age of 34 years. The process of axonal
degeneration, involving myelinated and unmyelinated axons, 
had advanced to a stage of near total loss of all myelinated 
fibres. Teased fibre studies of the femoral nerve, examined 
post-mortem, showed clustering of (secondary) segmental 
de- and remyelination.
■aci
4-c mitochondria,
Biochemical findings (Table 4)
For
o f
examination,
al M  I *
of fresh
to
Si
Skeletal muscle biopsies
Morphological changes
Muscle biopsy specimens of s 
patient B.S6 left ocular superior rectus,
F i g .  5 )
quadriceps, and in
s were stained
described previously (Fischer et a t . ,  1986; Trijbels e l a l ., 
1988). Oxidation rates of various substrates were measured 
radiochemically in fresh muscle supernatant, Adenosine
triphosphate and creatine phosphate production rates and 
oxidation rates of | l - l4C]pyruvate and |U -,4C|malatc were
determined in pari incubations, according to proee-
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Fig. 5 Muscle biopsy specimens. Electronmicroscopical abnormalities of mitochondria (A-D) and deficient COX-activity in light
microscopy (E and F). in A, B and C (arrows); absence of cristae in some or many mitochondria in A, C and
D; mitochondria with concentric cristae (star-symbol) in B and D; a degenerating mitochondrion in D (left). E and F represent
consecutive sections stained for myofibrillar ATPase (preincubation at pH 4.6) and COX, respectively. F shows one type-IIA fibre
(arrow) a • i'. \ /A are COX-deficient. Bars =  1 |im in A, C and D, 0.5 (im in B and 50 fj.m in E and F.
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dures described previously (Fischer et a l,  1986). In cases 0.25, with an early age of onset and consistent pattern of
A.S4, A.S6, B.S9 and C.FI COX and citrate synthase 
activities were determined to document respiratory chain 
activity. Fatty acid oxidation rates were based on the [1-14C]/ 
[U-,4C]palmitate ratio and found to be normal. Both oxydative 
phosphorylation and respiratory chain activity appeared 
normal.
Post-mortem neuropathological examination
(Fig. 6)
The brains weighed 1050 and 1235 g (normal 1200-1400 g) 
in cases A.S4 and B.S6, respectively. In both cases the spinal 
cord showed degeneration, with marked myelin pallor of the 
posterior columns, particularly the fasciculi graciles, and, to 
a lesser extent, of spinocerebellar tracts and dorsal roots 
(Fig. 6A). Only minor other pathological changes were found 
in case B.S6, who has been extensively described previously 
(Bastiaensen et al., 1977). Gross examination of case A.S4 
revealed a normal pattern of cerebral gyri, and a relatively 
small cerebellum and brainstem. At microscopic examination, 
local vacuolar change of the neuropil, accompanied by 
astrocytosis and loss of neurons was seen in the occipital 
cortex (Fig. 6B). Occasional blood vessels in the lentiform 
nucleus showed mineralization of the vessel wall. In the 
cerebellum, marked loss of neurons was noted in the dentate 
nucleus (Fig. 6C), whereas the Purkinje cell layer showed 
mild loss of cells. There were no pathological changes of 
nuclei pontes, pyramidal tracts and optical systems. The 
dorsolateral part of the substantia nigra and the inferior 
olivary nuclei showed moderate neuronal loss. Involvement of 
inferior olivary nuclei was confirmed by central chromatolysis 
and vacuolation of the cytoplasm of some remaining neurons, 
astrocytosis and loss of myelin in surrounding white matter
(Fig. 6D).
Genetic aspects
For mitochondrial DNA analysis
were obtained from the index patients from all families.
Screening for mtDNA gross rei 
point mutations 3460 
15.257, mitochondrial
depletion and
4160, 11.778, 14.484,
lactic
clinical signs.
Discussion
We present six patients from three unrelated families, with 
hereditary multisystem degeneration of the nervous system,
with insidious onset at adolescence and suspected autosomal
recessive inheritance. Symptoms and signs of the initial stage 
appeared to be the consequence of severe progressive sensory
ited fibres.neuropathy, leading to a near total 
Stage 2 is characterized by PEO, caused by ocular
ration : have contri
itaxia at this stage, in wheelchair
dependency after 10-20 years. Motor nerve involvement and 
myopathy remained sub-clinical. Stage 3 is characterized by 
the gradual evolvement of myoclonic jerks and the sudden 
onset of grand mal epilepsy, resulting in myoclonic epileptic 
status, which was the cause of premature death in four 
patients in the course of 1-3 years. Two patients (A.S3 and 
B.S9) apparently had a milder course of disease, with later 
onset (at about the age of 20) years and no seizures at the 
age of 40 and 51 years, respectively. Their EEG tracings, 
however, showed mild slowing of background with inter­
mittent paroxysmal bitemporal sharp waves (Patient A.S3)
slow-wave and spike-and-wave (3-4 s-1)or genen
discharges (Patient B.S9), similar to the initial recordings in 
Patients A.S4 and B.S6, before clinical signs of epilepsy 
were noted. In none of the patients was there evidence of 
optic atrophy, short stature or facial dysmorphias, cataract, 
nystagmus, abnormal breathing, stroke-like episodes, cardi­
omyopathy or cardiac conduction block, involvement of pyr­
amidal or extrapyramidal systems and classical retinitis
pigmentosa with bone spicule formation (Mullie e ta l ,
There were no significant atrophic changes of iniratentorial
s or on or MR I of
the head.
At first, it was considered that the cardinal clinical features
and post-mortem ngs might largely ; to the hetero-
berg and Grossman 
Harding,
ataxic s
; Su bra mo n y i 
none of the recently classified 
s an identical progression andand stroke-like episodes (MELAS) 3243, 3271, 3252, Leigh/ 
neuropathy, ataxia and retinitis pigmentosa (NARP) 8993, constellation of signs and cerebellar signs were only of minor 
and myoclonus epilepsy with ragged-red fibres (MERRF) importance in our cases. The loss of large myelinated nerve
8344, was negative in each No linkage with
Friedreich’s ataxia marker FD1 and D9S15 (Duclos et a l,  
1993) was detected.
fibres is also a common feature in s d ì  
(McLeod and Evans, 1981;
illar ataxias
None of the parents were const families had
rarely seen (Werde!in,
on CPEO-plus, some
not been related for several generations and lived far apart. incidental cases associated with ataxia and polyneuropathy
Autosomal recessive inheritance is the most likely mode of 
inheritance in our patients (Fig. 1): the disease was restricted 
to patients from one generation, there was no evidence of 
maternal inheritance and the segregation ratio was close to
> r  a
OUIt  f \  n n n  i i
; Drae
, and these might have been clinically similar to
s et a l,  1958; Jampel et a I,
; Croft et a l ,an,
1977; Bastiaensen,
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they have been less completely specified, morphologic­
ally, biochemically or genetically, ancl did not in
myoclonic status epilepticus. Generally, CPEO-plus is 
associated nowadays most particularly with mitochondrial 
myopathy (Berenberg et al., 1977; Mitsumoto et al., 1983; 
Rowland, 1992).
The initial progressive ataxia, in our cases, seemed to be 
caused primarily by the progressive sensory neuropathy, 
resulting in an irregular broad-based gait. Although the
ciency (Fig. 5E and F). Assessment of oxidative phosphoryla­
tion and adenosine triphosphate production rate, revealed no 
further relevant biochemical changes in muscle specimens. 
A lack of correlation between the measurable metabolic 
defects and the clinical features in MEM syndromes is not 
uncommon (Lombes et al., 1989; DiMauro and De Vivo, 
1994). A characteristic clinical spectrum of mitochondrio-
:e suggests that 
the myopathy
morphological features of sural nerve biopsies are
not exist, and increasing 
nervous system involvement may overshi 
in MEM f
qualitatively reminiscent of the neuronopathy in Friedreich’s
ataxia (Said et 
worsening in
1986; Caruso et
re ic h  s a ta x ia  í
clinical
Moreover, some 
*omes are considered candidates for mito­
chondrial disease in the current literature (Blass et a l ,  
Harding, 1991; Sorbi and Blass, 1 Early degeneration
hasataxias is more specifically related to progressive involvement of spinocerebellar tracts and Clarke’s 
of spinal and cerebellar pathways, with relatively stable 
involvement of the peripheral myelinated fibres (Harding,
1981; Santaro et a l ,  1990). Together with the ataxia, the 
painful dysaesthesias and the sensory impairment of the legs
and lower trunk, the abnormalities of the sural nerves to substantiate a possible causal connection of mitochondrial
disease with certain heredo-ataxic syndromes.
Both KSS and MERRF have some characteristic features
to be caused by experimental COX 
1989). Sensory axonal neuropathy has been reported
in association with partial 
(Pezeshkpour et al. 1987). But further studies are required
support pathogenetic similarity with the central-peripheral 
axonopathy, in which both centrally and peripherally directed 
axons of the primary sensory neurons degenerate, as a in common with the syndrome in our patients. Progressive 
possible consequence of toxic/metabolic changes or defects external ophthalmoplegia and myoclonus epilepsy are non­
in energy metabolism (Thomas, 1982; Cavanagh, 1984). specific clinical signs, occurring in a variety of disease states.
neuropathy, reported so far in MEM The absence of retinitis pigmentosa, heart block, significant
syndromes, was not of an uniform nature. Sural nerve biopsies increase of CSF protein and the severe polyneuropathy with
either suggested chronic axonal degeneration or showed autosomal recessive inheritance, are evidence against the
primary demyelination (Yiannikas et al., 1986; Mizusawa diagnosis of KSS (Berenberg et a l ,  1977; Rowland, 1992).
The
et a l ,  1991). A demyelinating radiculopathy has Progressive myoclonus in our patients was not a prominent
reported in some cases of Kearns-Sayre syndrome (KSS) sign, but preceded the myoclonic epileptic status for some 
(Groothuis et al., 1980). Electrophysiologieally the most time in three patients (A.S4, A.S6 and B.S6). Previous reports
common were a relatively mild of
conduction and decreased sensory nerve action potentials, 
particularly in the lower limbs (Peyronnard et a l .
on heredo-ataxic syndromes with peripheral neuropathy and
mostly
mutant mtDNA et al.. Marsden et a l ,
1990; Silvestri et a l ,  1993; Sweeney et a l ,  1994). From a
partially overlapping
Eymard et a l ,  1991). It may be difficult to derive from these neuropathy, ataxia and retinitis pigmentosa/Leigh 
data retrospectively whether the primary process leading to 
the neuropathy, in those patients, might have been caused 
directly by mitochondrial dysfunction, and whether the 
neuropathy is axonal in nature or primarily demyelinating.
However, there is growing evidence of a more widespread 
incidence and range of polyneuropathy in MEM syndromes 
(Yiannikas et a l ,  1986; Schroder and Sommer, 1991).
morphological of view, 
inferior olivary
of brainstem
u m
(particularly dentate nucleus), spinal posterior columns and
ar tracts have r as additional
neuropathological findings in both KSS and MBRRF(Sparaco 
t a l ,  1993). The vaeuolation in cortical cells anil brainstemt
neurons, with spongiform changes of the occipital cortex and 
Mitochondrial involvement  siderocalciiic deposits in basal ganglia, that were shown in
The multisystem disorder in our patients most particularly our case A.S4, are similar findings to those in cases of KSS
and other MEM syndromes (Berenberg et a l , 1977; Groothuisstands out from other heredo-ataxic syndromes for 
consistent elevation of CSF lactate (with variable elevation 
of lactate in blood and urine), in an early stage. Exercise 
was not tolerated well, and all patients complained of fatigue 
and psychic lability. All but one patient showed ragged-red 
fibres, and morphological changes of muscle mitochondria. 
In the remaining patient (B.S9) the number of subsarcolemmal 
mitochondria was increased and paracrystalline inclusions
et a l ,  1980; McKelvie et a l ; Sparaco et a l .
But mtDNA deletions, in various
> < 1 U ï\ CJ S (Moraes et al., 1989; Degoul et a l ,
1991), nor the mtDNA mutations of 
ataxia and retinitis pigmentosa
in our cases.
? and neuropathy, 
et a l ,  1990) could be
the classification of MEM syndromes, based on
were observed. Light microscopic examination of the muscle clinical signs, is threatened by nosological chaos, clinical
biopsy specimen in patient A.S6 revealed focal COX deli - practice is rather insistent on symptoms that might corroborate
1008 P. H. M. F. van Domburg et al.
an association with mitochondrial disorder (DiMauro and et al., 1991; Ross et al., 1994). Peripheral neuropathy was
Moraes, 1993). Apart from the mild visual impairment in not an uncommon finding in such cases, the symptoms
Patients A.S4 and B.S6, sensorineural hearing loss in Patients progressed with the increasing age and many patients died
B .S9 and C.F1, and atypical pigmentary changes of the retina prematurely in their 40s or 50s, presumably due to a metabolic
in Patients B.S6 and B.S9, the severe episodic diarrhoea in crisis (Haltia et a l ,  1992).
Patients A.S3 and C.F1 was remarkable. Gastrointestinal In conclusion, we propose a nuclear DNA defect in some
signs (particularly pseudo-obstruction syndrome) in combina- way affecting mitochondrial function, as the most likely
tion with ophthalmoplegia, axonal neuropathy, and potential molecular genetic background, in this disorder which cannot
CNS involvement is a well-defined autosomal recessive be categorized in current classifications, 
hereditary condition (Steiner e t a i ,  1987; Simon et al,, 1990).
Although the pathogenesis might be obscure in these cases,
mitochondrial involvement was evident in closely related Acknowledgements
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tion (Patient A.S3), the hyperhidrosis, orthostatic hypotension 
(Patient A.S6), a tendency to urine retention with recurrent
cystitis (A.S3, A.S4, A.S6, C.S9), and keratitis sicca (A.S6 
and C.S9) might suggest that, in our patients, the autonomic 
nervous system was also involved. Furthermore, the aggrava­
tion after pregnancy (Patients A.S4, A.S3 and B.S6) and 
the ultimate culmination in unbeatable myoclonic status
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